Seasonal Human Coronavirus Respiratory Tract Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation

  • Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation and Infectious Complications Subcommittee of the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH)
  • , Jose Luis Piñana
  • , Aliénor Xhaard
  • , Gloria Tridello
  • , Jakob Passweg
  • , Anne Kozijn
  • , Nicola Polverelli
  • , Inmaculada Heras
  • , Ariadna Perez
  • , Jaime Sanz
  • , Dagmar Berghuis
  • , Lourdes Vázquez
  • , María Suárez-Lledó
  • , Maija Itäla-Remes
  • , Tulay Ozcelik
  • , Isabel Iturrate Basarán
  • , Musa Karakukcu
  • , Mohsen Al Zahrani
  • , Goda Choi
  • , Marián Angeles Cuesta Casas
  • Montserrat Batlle Massana, Amato Viviana, Nicole Blijlevens, Arnold Ganser, Baris Kuskonmaz, Hélène Labussière-Wallet, Peter J Shaw, Zeynep Arzu Yegin, Marta González-Vicent, Vanderson Rocha, Alina Ferster, Nina Knelange, David Navarro, Malgorzata Mikulska, Rafael de la Camara, Jan Styczynski

    Research output: Contribution to journalArticleAcademicpeer-review

    26 Citations (Scopus)
    103 Downloads (Pure)

    Abstract

    Background. Little is known about characteristics of seasonal human coronaviruses (HCoVs) (NL63, 229E, OC43, and HKU1) after allogeneic stem cell transplantation (allo-HSCT).

    Methods. This was a collaborative Spanish and European bone marrow transplantation retrospective multicenter study, which induded allo-HSCT recipients (adults and children) with upper respiratory tract disease (URTD) and/or lower respiratory tract disease (LRTD) caused by seasonal HCoV diagnosed through multiplex polymerase chain reaction assays from January 2012 to January 2019.

    Results. We included 402 allo-HSCT recipients who developed 449 HCoV URTD/LRTD episodes. Median age of recipients was 46 years (range, 0.3-73.8 years). HCoV episodes were diagnosed at a median of 222 days after transplantation. The most common HCoV subtype was OC43 (n = 170 [38%]). LRTD involvement occurred in 121 episodes (27%). HCoV infection frequently required hospitalization (18%), oxygen administration (13%), and intensive care unit (ICU) admission (3%). Three-month overall mortality after HCoV detection was 7% in the whole cohort and 16% in those with LRTD. We identified 3 conditions associated with higher mortality in recipients with LRTD: absolute lymphocyte count

    Conclusions. Seasonal HCoV after allo-HSCT may involve LRTD in many instances, leading to a significant morbidity.

    Original languageEnglish
    Pages (from-to)1564-1575
    Number of pages12
    JournalThe Journal of Infectious Diseases
    Volume223
    Issue number9
    Early online date29-Aug-2020
    DOIs
    Publication statusPublished - 1-May-2021

    Keywords

    • seasonal human coronavirus
    • HCoV-NL63
    • HCoV-229E
    • HCoV-OC43
    • HCoV-HKU1
    • community-acquired respiratory virus
    • allogeneic hematopoietic stem cell transplantation
    • immunocompromised
    • upper and lower respiratory tract disease
    • immunodeficiency score index
    • multiplex PCR assay
    • CLINICAL CHARACTERISTICS
    • PARAINFLUENZA VIRUS
    • NL63 INFECTIONS
    • SYNCYTIAL VIRUS
    • PNEUMONIA
    • DISEASE
    • RHINOVIRUS
    • DIAGNOSIS
    • OUTCOMES
    • CHINA

    Fingerprint

    Dive into the research topics of 'Seasonal Human Coronavirus Respiratory Tract Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation'. Together they form a unique fingerprint.

    Cite this